Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases

NCT01646554 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Conditions

Colorectal Cancer Metastatic
Liver Metastases
KRAS Mutated Colorectal Cancer

Interventions

DRUG: Modified FOLFOX6
BIOLOGICAL: Aflibercept
PROCEDURE: Surgery

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]